Compare Amphastar Pharmaceuticals Inc (AMPH) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Verisign, Inc. — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Verisign, Inc. trades at $287.62 (market cap $26.00B). The key difference: Verisign, Inc. is far larger — about 29.9× Amphastar Pharmaceuticals Inc's market cap, and Verisign, Inc. pays a 1.13% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | VRSN | |
|---|---|---|
Market Cap | $868.62M | $26.00B |
Sector | Health | Technology |
52-Week High | $30.81 | $310.00 |
52-Week Low | $16.87 | $211.49 |
Enterprise Value | $1.27B | $27.31B |
Dividend Yield | — | 1.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
